Irhythm Holdings, Inc. current report, 28 March 2022

Business Context and Reporting Period

Company: iRhythm Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 28, 2022
Event: Entry into a Material Definitive Agreement (Second Amendment to Loan and Security Agreement with Silicon Valley Bank).

Key Financial Metrics and Debt Structure

This filing details a restructuring of the Company's debt facilities rather than reporting operational financial results (revenue, profit, or cash flow) for a specific period.

  • Existing Term Loan: Approximately $18.5 million outstanding as of March 28, 2022, which was paid in full using proceeds from the new facility.
  • New Term Loan Facility (2022 Term Loans): Aggregate principal amount up to $75.0 million.
  • Initial Borrowing: $35.0 million borrowed at closing.
  • Remaining Availability: $40.0 million available for borrowing in increments of at least $10.0 million through December 31, 2023.
  • Revolving Credit Line: Aggregate principal amount up to $25.0 million. No loans were outstanding as of March 29, 2022.
  • Letters of Credit Sublimit: Increased to $15.0 million.
  • Cash Management Services Sublimit: Increased to $15.0 million.

Material Changes Versus Prior Period

The Amendment significantly altered the Company's credit terms compared to the prior agreement:

  • Term Loan Capacity: Increased from an original $35.0 million term loan to a new facility of up to $75.0 million.
  • Maturity Extension: The Revolving Credit Line maturity date was extended from August 1, 2023, to March 1, 2027.
  • Repayment Terms: The 2022 Term Loans require interest-only payments until April 1, 2025, followed by 24 equal monthly installments, with full maturity on March 1, 2027.
  • Interest Rate: Set at a floating rate equal to the greater of (A) Prime Rate plus 0.25% or (B) 3.50% for both the Term Loans and Revolving Credit Line.
  • Fees: Prepayment fees range from 3.0% to 1.0% depending on the date; a final payment of 5.0% of the principal amount is required. An annual fee of 0.15% applies to the Revolving Credit Line.

Guidance, Risks, and Covenants

The filing does not provide forward-looking guidance on revenue or earnings. However, it establishes new financial covenants and risks:

  • Financial Covenants: The Company must maintain, as of the last day of each fiscal quarter, either a quick ratio of at least 1.15 to 1.0 or a minimum Adjusted EBITDA of at least $15.0 million.
  • Reborrowing Restriction: Once the 2022 Term Loans are repaid or prepaid, they may not be reborrowed.
  • Prepayment Risk: Early repayment incurs significant fees (up to 3.0%) plus a mandatory 5.0% final payment.

Important Facts for Investor Verification

  • Verify the Company's current Adjusted EBITDA and quick ratio to ensure compliance with the new covenants (minimum $15.0 million Adjusted EBITDA or 1.15 quick ratio).
  • Confirm the total debt load on the balance sheet reflects the $35.0 million new term loan and the extinguishment of the prior $18.5 million loan.
  • Monitor the utilization of the remaining $40.0 million term loan availability and the $25.0 million revolving line.
  • Review the impact of the 5.0% final payment fee and potential prepayment penalties on future liquidity planning.